Ieq Capital LLC buys 2,075 shares of HCA Healthcare, Inc. (NYSE:HCA)

VaselineSeptember 22, 2024

0 5 minutes read

Ieq Capital LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 32.8% during the second quarter, HoldingsChannel reports. The fund owned 8,408 shares of the company’s stock after purchasing an additional 2,075 shares during the quarter. Ieq Capital LLC’s holdings in HCA Healthcare were worth $2,701,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the company. Royal Bank of Canada raised its holdings in shares of HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after buying an additional 1,183,890 shares during the last quarter. Capital World Investors boosted its holdings in HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares in the last quarter. Sanders Capital LLC boosted its position in shares of HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after buying an additional 456,738 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in HCA Healthcare in the second quarter valued at $131,527,000. Finally, TD Asset Management Inc raised its stake in shares of HCA Healthcare by 230.5% in the fourth quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after purchasing an additional 385,854 shares in the last quarter. 62.73% of the shares are currently held by institutional investors.

Analysts on Wall Street are forecasting an increase

A number of equities research analysts have issued reports on the stock. Royal Bank of Canada boosted their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. JPMorgan Chase & Co. raised their target price on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Barclays boosted their price target on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective for the company. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $359.89.

Want more great investment ideas?

Check out our latest analysis of HCA Healthcare

Insider activity at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the SEC, which is available on the SEC’s website. In other news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the SEC, which is available on the SEC’s website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock worth $6,407,273 over the last quarter. 1.60% of shares are owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $404.66 on Friday. The stock has a market cap of $105.99 billion, a PE ratio of 20.17, a PEG ratio of 1.46 and a beta of 1.67. The company’s fifty-day moving average is $370.57, and its 200-day moving average is $340.65. The company has a quick ratio of 0.94, a current ratio of 1.06, and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. it has a 52-week low of $215.96 and a 52-week high of $405.70.

HCA Healthcare (NYSE:HCA – Get Free Report ) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same period in the previous year, the firm earned $4.29 EPS. The company’s quarterly revenue was up 10.3% year over year. Research analysts anticipate that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare announces dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a dividend of $2.64 on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend is Monday, September 16. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic and emergency services; and outpatient services such as ambulatory surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.